3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
5
Breast Neoplasms
4
Neoplasm Metastasis
3
Lung Neoplasms
3
Colorectal Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Multiple Myeloma
2
Lymphoma
2
Glioblastoma
2
Urinary Bladder Neoplasms
1
Stroke
1
Stress Disorders, Post-Traumatic
1
Recurrence
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Myelodysplastic Syndromes
1
Motor Activity
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hematologic Neoplasms
1
Fallopian Tube Neoplasms
1
Interventions
Doxorubicin
13
Specimen Handling
12
pembrolizumab
11
Magnetic Resonance Spectroscopy
10
Biopsy
10
Cyclophosphamide
9
X-Rays
7
Ifosfamide
7
Radiotherapy
6
Phantoms, Imaging
6
Gemcitabine
6
liposomal doxorubicin
5
Nivolumab
5
tazemetostat
4
palbociclib
4
fludarabine
4
atezolizumab
4
Temozolomide
4
Radiation
4
Nuclear Medicine Department, Hospital
4
Irinotecan
4
larotrectinib
3
cabozantinib
3
Surveys and Questionnaires
3
Ipilimumab
3
Carboplatin
3
Bevacizumab
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma
×
Palliative Care
×
90 days
×
Clear all
No trials found.